4:04pm ET
Investing
Celgene, Campbell’s Soup Drop into Monday’s 52-Week Low Club
Celgene, Campbell's Soup, Banco Santander, and Teekay Tankers all posted new 52-week lows on Monday.
Companies
Celgene
$108.24
▲ $0.00 (+0.00%) today
Markets open · 3:41pm ET
CELG Coverage
Page 5
4:04pm ET
Investing
Campbell Soup, Celgene Stumble into Friday’s 52-Week Low Club
Campbell Soup, Cemex, Celgene, and Coty all posted new 52-week lows Friday.
4:04pm ET
Investing
Celgene, NetEase Drop into Thursday’s 52-Week Low Club
Celgene, NetEase, PPL Corp., and Vodafone all posted new 52-week lows Thursday.
10:40am ET
Health and Healthcare
Big Biotechs Scare Off Short Sellers
The April 30 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
4:04pm ET
Investing
Tower Semiconductor, Celgene Drop into Monday’s 52-Week Low Club
Tower Semiconductor, Cemex, Celgene, and Sibanye Gold all posted new 52-week lows Monday.
8:40am ET
Health and Healthcare
Major Biotechs Face Rising Tide of Short Interest
The April 13 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
9:05am ET
Health and Healthcare
Short Sellers Back Way Off Major Biotechs
The March 29 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
9:45am ET
Health and Healthcare
Celgene Shuffles the Deck: COO Steps Down Immediately
Celgene is shuffling the deck in terms of its executive leadership, and one of its top executives is stepping down.
Chris Lange 9:30am ET
Health and Healthcare
Major Biotechs See Rising Tide in Short Interest
The March 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
9:45am ET
Health and Healthcare
Prothena Climbs on Celgene Collaboration
This collaboration with Celgene looks like a chance for Prothena to really shine, especially considering that it has had a rough run of 2018 so far.
Chris Lange 9:05am ET
Investing
Top Analyst Upgrades and Downgrades: Applied Materials, Celgene, Children’s Place, Kinder Morgan, Match, Myriad Genetics, Nordstrom, Oracle and More
The top analyst upgrades, downgrades and other research calls from Wednesday include Applied Materials, Celgene, Children's Place, Kinder Morgan, Match, Myriad Genetics, Nordstrom and Oracle.
9:45am ET
Health and Healthcare
Major Biotechs: Tough Call for Short Sellers
The February 28 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.
11:50am ET
Health and Healthcare
Merrill Lynch’s Top Biotech Acquisition Targets in 2018
Merrill Lynch has taken a look at the biotech industry and made a few picks that could play out in 2018.
4:04pm ET
Investing
Celgene, Weatherford Drop into Wednesday’s 52-Week Low Club
Celgene, Weatherford International, Akorn, and Cemex all posted new 52-week lows on Wednesday.
1:15pm ET
Health and Healthcare
Why the Celgene Damage May Be an Overreaction
Celgene watched its shares drop on Wednesday after the company announced that it received a Refusal to File letter from the FDA.
Chris Lange